Opal Biosciences buys drug development business, eyes manufacture

Infections diseases therapy company Opal Biosciences has bought a specialist pharmaceutical formulation business, boosting its capabilities in developing new drugs for clinical trials and manufacture. The Melbourne company bought Formulytica Pty Ltd which has in-house laboratories for developing formulations for topical and injectable drugs. The company provides a fee-for-service business for local and international clients…

Softmed onshores production of surgical wrap

Australia’s largest personal protective equipment (PPE) manufacturer, Softmed, has begun producing one million sterilisation wraps per month which are used to wrap and seal surgical trays and instruments prior to surgical procedures. The company, which in August invested $30 million in a new Victorian factory, began local production in response to a critical worldwide shortage…

ARENA announces $103 million in grant funding for three large-scale green hydrogen projects

The Australian Renewable Energy Agency (ARENA) has announced conditional approval of $103.3 million grant support for three large-scale green hydrogen projects through its Renewable Hydrogen Deployment Funding Round. The successful projects: Engie Renewables Australia Pty Ltd (Engie): ARENA will provide up to $42.5 million towards a 10 MW electrolyser project to produce renewable hydrogen in…